Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Pikul has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Rzepakowska

    Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland

    5 shared publications
  • Tomasz Stokłosa

    Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland

    2 shared publications
  • Agata Mormul

    Department of Internal Medicine Praski Hospital in Warsaw Poland

    1 shared publication
  • Agnieszka Chudy

    Laboratory of Genetics, University Clinical Hospital, Medical University of Warsaw, Warsaw, Poland

    1 shared publication
  • Albert Moskowicz

    Laboratory of Genetics, University Clinical Hospital, Medical University of Warsaw, Warsaw, Poland

    1 shared publication
  • Andrzej Deptała

    Department of Oncology Propaedeutics, Medical University of Warsaw, Warsaw, Poland. 2. Department of Oncology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland

    1 shared publication

Latest Publications

  • Open Access

    MicroRNAs in Salivary Gland Cancers Associated with Poor Prognosis: A Systematic Review

    by Julia Pikul, Maja Cieślik, Kazimierz Niemczyk, Anna Rzepakowska

    Salivary gland cancers (SGCs) are rare and heterogeneous tumours, making the identification of reliable prognostic biomarkers challenging. MicroRNAs (miRNAs) regulate post-transcriptional gene expression and may play important roles in tumour progression and treatment response. This systematic review aims to identify and summarize the current evidence on miRNA dysregulation in SGCs, with a particular focus on their prognostic relevance and therapeutic potential. A systematic search of PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library was conducted up to 3 December 2025, following PRISMA guidelines and a pre-registered protocol (CRD420251231827). Observational cohort and cross-sectional studies reporting microRNA dysregulation in human salivary gland tissues with prognostic assessment were included. Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. Due to considerable heterogeneity, a narrative synthesis was conducted. Twenty studies published between 2013 and 2025 that fulfilled the search criteria were further analyzed. Based on the currently available evidence, dysregulation of miRNAs associated with prognosis has been identified only in adenoid cystic carcinoma (AdCC) and mucoepidermoid carcinoma (MEC). Most studies originated from Asia and used qRT-PCR for miRNA assessment. Most researchers focused on the evaluation of selected candidate miRNAs, rather than conducting comprehensive miRNA profiling approaches in relation to prognosis. Several distinct dysregulated miRNAs were identified across the studies. Among them, miR-9, miR-21, miR-24 miR-29, miR-34c-5p, miR-125a-5p, miR-143, miR-145 and miR-205 were reported in more than one study and linked to clinicopathological advancement and a more aggressive disease course, thus leading to a poorer outcome. MiRNAs appear to represent promising prognostic biomarkers, either as independent predictors or in combination with established clinicopathological features. However, current evidence remains limited to selected histological subtypes and relatively small patient cohorts. Further well-designed studies with long-term follow-up are required. Moreover, comprehensive miRNA profiling with prognosis assessment is necessary before specific miRNAs could be reliably established as biomarkers and utilized in daily clinical practice.


  • Open Access

    Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas

    by Julia Pikul, Marcin M. Machnicki, Anna Rzepakowska, Natalia Winiarska, Agnieszka Chudy, Albert Moskowicz, Kacper Król, Łukasz Fus, Grażyna Kostrzewa, Tomasz Stokłosa

    The study was designed to evaluate molecular alterations, relevant to the prognosis and personalized therapy of salivary gland cancers (SGCs). DNA was extracted from archival tissue of 40 patients with various SGCs subtypes. A targeted next-generation sequencing (NGS) panel was used for the identification of small-scale mutations, focal and chromosomal arm-level copy number changes. The final analysis included selected genes with potential actionable aberrations for targeted therapies and outcome predictions in 37 tumours’ samples. The follow-up of the SGCs study cohort revealed disease recurrence or metastasis in 19 patients and indicated poor individual outcomes. The mean disease-free survival (DFS) within the poor outcome group was 2.4 years, and the overall survival (OS) was 5.4 years. The DFS and OS of the remaining 18 patients with favourable outcomes were 8.3 years. The genes most frequently affected with aberrations were NF1 (n = 9, 24%) and TP53 (n = 8, 22%), with increased occurrence observed in the poor outcome group: NF1 (n = 6, 32%) and TP53 (n = 6, 32%). CDKN2A biallelic deletion was the most common copy number variation (n = 5), and was detected in 4 cases with identified disease relapse. TERT promoter mutation and amplification were found in myoepithelial carcinoma. A p.Ile35Thr mutation was discovered in CTNNB1 in two cases of adenoid cystic carcinoma. ERBB2 alterations were remarkable for SDC ex PA. Furthermore, TP53 mutation was established as a relevant negative prognostic factor for overall survival (p = 0,04). The analysis revealed potentially actionable genes in detected alterations in: MECA 100% (1/1), SDC 100% (7/7), AD 92% (11/12), Ca ex PA 82% (18/22), MECA 65% (20/31), AdCC 64% (9/14) and AcCC 0% (0/1). SGCs are a heterogeneous group of malignancies with distinct molecular landscape that characterized by poor prognosis and inadequate treatment options. Nonstandard strategies might be beneficial for patients who suffer from salivary gland cancers. Wider utilization of NGS analysis may increase the opportunity for patients with those rare cancers to receive more precise, personalized therapy.


  • Open Access

    Awareness about colorectal cancer among young adults in Poland

    by Marta Fudalej, Julia Pikul, Agata Mormul, Andrzej Deptała, Anna Badowska-Kozakiewicz

    Purpose: The present study aimed to evaluate the knowledge and awareness level concerning colorectal cancer epidemiology, risk factors, symptoms, and prevention among young people in Poland. Methods: The knowledge was examined with an anonymous survey between February and March 2021. The data were collected anonymously, and the participation was voluntary. Statistical analysis was performed, and differences were considered significant if the p-value obtained was smaller than the assumed level of significance p ≤0.05. Results: Respondents were mostly female, living in a city with a population of over 500,000. The results confirmed that education, family/friends’ history of CRC, and a place of residence differentiate knowledge and awareness about CRC. Conclusion: The study acquired information that might guide educators about knowledge deficits among young people in Poland. The survey results revealed a significant knowledge gap between rural and urban inhabitants as well as between medical and non-medical groups.

  • Open Access

    Oncologic outcomes of the most prevalent major salivary gland cancers: retrospective cohort study from single center

    by Ewa Kucharska, Anna Rzepakowska, Michał Żurek, Julia Pikul, Piotr Daniel, Angelika Oleszczak, Kazimierz Niemczyk

    Background: The preoperative diagnosis of salivary gland cancer (SGC) is crucial for the application of appropriate treatment, particularly involving the extension of the resection. Methods: Retrospective search of medical database identified 116 patients treated surgically with malignant tumors of salivary gland between 2010 and 2020. Analysis included the demographical data, clinical course, type of surgical and adjuvant treatment, histology type and margin status, perivascular invasion (LVI), perineural invasion (PNI), metastatic lymph nodes (LN). Facial nerve function, recurrence-free and overall survival were evaluated. Adequate statistics were used for data analysis. Results: The final cohort included 63 SGC patients, with adenoid cystic carcinoma the most common pathological type (27%, n = 17), followed by adenocarcinoma (17.4% n = 11). T1 and T2 patients accounted for majority cases (n = 46). The lymph node metastases were confirmed with the histopathology in 31.7% (n = 20). Distant metastases were observed in 4.8% of cases (n = 3). 38% (n = 24) of SGC were treated selectively with surgery, 49.2% (n = 31) had postoperative radiotherapy and 15.9% (n = 10)—radio-chemotherapy. The final facial nerve function was impaired in 38% of patients. Mean overall survival (OS) for all patients was 108.7 (± 132.1) months, and was the most favorable for acinar cell carcinoma (118.9 ± 45.4) and the poorest for squamous cell carcinoma (44 ± 32). Cox regression analysis of disease-free survival and OS identified significant association only with patients’ age over 65 years, the hazard ratio of 7.955 and 6.486, respectively. Conclusions: The efficacy of treatment modalities for SGC should be verified with regard to the histopathological type, but also the patients’ age should be taken into account.


  • Open Access

    Molecular landscape of salivary gland malignancies. What is already known?

    by Julia Pikul, Anna Rzepakowska

    Salivary gland carcinomas (SGCs) are highly heterogeneous histopathological entities that arise in either the major or minor salivary glands. Although uncommon, these tumours exhibit considerable aggressiveness, unpredictable progression, and significant mortality. The fifth edition of the World...


  • Open Access

    FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma

    by Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stokłosa

    Introduction: Salivary gland tumours are rare neoplasms. Pleomorphic adenoma (PA) is the most frequent benign lesion. Myoepithelial carcinoma (MECA) is rarely recognized malignancy, but the prognosis is unfavourable. The aim of this study was to identify genetic rearrangements that might be...


  • Open Access

    The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome

    by Anna Dunalska, Julia Pikul, Katarzyna Schok, Katarzyna Anna Wiejak, Piotr Alster

    Corticobasal syndrome (CBS) is a clinical entity, classified as an atypical Parkinsonism, characterized by both motor and higher cortical dysfunctions. The clinical manifestation of CBS is associated with several pathologies, among which corticobasal degeneration (CBD) is the most common. The aim of our study was to elaborate on the possible vascular pathogenesis of CBS and consider types of vascular lesions in these cases. Several cases of vascular CBS are described in the literature. The majority of presented patients were affected by internal carotid artery (ICA) stenosis and ischemic strokes; few cases were associated with vascular malformations or autoimmune diseases. Vascular CBS is preceded by an abrupt onset. The clinical manifestation does not significantly differ with non-vascular CBS. Patients with vascular CBS are usually elderly; often with coexistent hypertension, dyslipidemia and diabetes mellitus. Inferring from our observations, cerebral hypoperfusion can play a significant role in neuropathological changes in neurodegenerative diseases. To the best of our knowledge paper is the first comprehensive review of vascular CBS and we are positive that our observations show that further research concerning the vascular pathogenesis of tauopathy atypical Parkinsonism is required.


  • Open Access

    Serum bilirubin concentration as a marker of severity of acute appendicitis

    by Maciej Jastrzębski, Maciej Krasnodębski, Michalina Szczęśniak, Michał Wierzchowski, Julia Pikul, Dariusz Jabłoński, Michał Grąt, Tadeusz Wróblewski, Krzysztof Zieniewicz

    Introduction Acute appendicitis (AA) is one of the most common causes of urgent admission to the hospital. Clinically applicable classification distinguishes simple and complex inflammation. Among commonly used inflammation markers of AA, bilirubin concentration is not well studied and thus is...